DafinchiHims & Hers' Strategic Focus on AI, Capex, and Global Growth in 2026
Hims & Hers is prioritizing AI infrastructure, international market expansion, and targeted capital investments in 2026 to accelerate growth and expand global footprint.
Read post
Detailed company information
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 10, 2026
Earnings Transcript for 2026 - Q1Released: May 11, 2026
Earnings Transcript for 2025 - Q4Released: Feb 23, 2026
Earnings Transcript for 2025 - Q3Released: Nov 03, 2025
Earnings Transcript for 2025 - Q2Released: Aug 04, 2025
Earnings Transcript for 2025 - Q1Released: May 05, 2025
Earnings Transcript for 2024 - Q4Released: Feb 24, 2025
Earnings Transcript for 2024 - Q3Released: Nov 04, 2024
Earnings Transcript for 2024 - Q2Released: Aug 05, 2024
Earnings Transcript for 2024 - Q1Released: May 06, 2024
Earnings Transcript for 2023 - Q4Released: Feb 26, 2024
Earnings Transcript for 2023 - Q3Released: Nov 06, 2023
Earnings Transcript for 2023 - Q2Released: Aug 07, 2023
Earnings Transcript for 2023 - Q1Released: May 08, 2023
Earnings Transcript for 2022 - Q4Released: Feb 27, 2023
Earnings Transcript for 2022 - Q3Released: Nov 07, 2022
Earnings Transcript for 2022 - Q2Released: Aug 08, 2022
Earnings Transcript for 2022 - Q1Released: May 09, 2022
Earnings Transcript for 2021 - Q4Released: Feb 22, 2022
Earnings Transcript for 2021 - Q3Released: Nov 10, 2021
Earnings Transcript for 2021 - Q2Released: Aug 11, 2021
Earnings Transcript for 2021 - Q1Released: May 18, 2021
IPAR Inter Parfums, Inc.
ELF e.l.f. Beauty, Inc.
COTY Coty Inc.
NWL Newell Brands Inc.
EL The Estée Lauder Companies Inc.
CL Colgate-Palmolive Company
PG The Procter & Gamble Company
SKIN SkinHealth Systems Inc.
OGN Organon & Co.
HQY HealthEquity, Inc.
AMWL American Well Corporation
HAIN The Hain Celestial Group, Inc.
Hims & Hers is prioritizing AI infrastructure, international market expansion, and targeted capital investments in 2026 to accelerate growth and expand global footprint.
Read post